Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
01/08/2008 | CA2258712C Asymetric synthesis of chiral beta-amino acids |
01/03/2008 | WO2008002087A1 Unsaturated alkyl esters of 5-aminolevulinic acid, their preparation and their use |
01/03/2008 | US20080004455 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
01/03/2008 | US20080004451 Pseudo proline dipeptides |
01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
01/03/2008 | US20080004321 Potentiators of Glutamate Receptors |
01/03/2008 | DE102006029830A1 Growing of deuterated alanine doped triglycine sulfate monocrystals from a solution for night vision device, comprises arranging a crystal holder in a chamber of a device and pumping the solution in a circulation with the chamber |
01/02/2008 | EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
01/02/2008 | CN101096345A Method for preparing chirality 2-hydroxyl group-3-amino-benzene ethylformic acid or its ester |
01/01/2008 | US7314955 Crystalline form "C"; amidating D-phenylalanine methyl ester hydrocholoride with trans-4-isopropylcyclohexane carboxylic acid in a halogenated hydrocarbon; hydrolyzing to form free acid |
01/01/2008 | US7314951 Biodegradation% |
01/01/2008 | US7314950 Sulfinating a trans-alkyl 4-aminocyclohexanecarboxylate (formed by iminating the cis-analog with a benzaldehyde and hydrolyzing the product) with an alkanesulfinyl chloride and oxidizing the product to form an alkyl 4-alkylsulfonamidocyclohexanecarboxylate, which then may be hydrolyzed |
01/01/2008 | US7314890 7-[[5-Hydroxy-5-(1-propylcyclobutyl)pent-2enyl] methanesulfonylamino] heptanoic acid ethyl ester; lowering intraocular pressure, glaucoma |
01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
12/27/2007 | WO2007045593A3 Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
12/27/2007 | US20070298129 Compounds and compositions for treating neuronal death or neurological dysfunction |
12/26/2007 | EP1870403A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing -amino acid and derivative thereof with the same |
12/26/2007 | EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
12/26/2007 | EP1868985A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
12/26/2007 | CN200995995Y Co-production line of lysine with different purities |
12/26/2007 | CN101092373A Method for synthesizing optically active derivative of 5 ¿C aryl ¿C (S) ¿C N ¿C boc ¿C alpha amino pentanoic acid |
12/26/2007 | CN101092372A Method for practical synthesizing optically active alpha amino pimelic acid ester or monoester |
12/26/2007 | CN101092371A Method for synthesizing optically active derivative of omega - aryl ¿C (2S) ¿C N ¿C boc ¿Calpha amino acid |
12/26/2007 | CN101092370A Method for practical synthesizing optically active 2 ¿C amido ¿C 8 - butenic acid |
12/26/2007 | CN101092369A Method for preparing iminodiacetic acid by using raw material of hydroxy acetonitrile |
12/26/2007 | CN101092368A Method for synthesizing 2 ¿C amido ¿C 9 - capric olefine acid |
12/26/2007 | CN100357274C Diaryl-enynes |
12/26/2007 | CN100357258C Production of keto acids |
12/25/2007 | US7312361 Inhibitors of transthyretin amyloid fibril formation |
12/25/2007 | US7312353 Cathespin cysteine protease inhibitors |
12/25/2007 | US7312343 N-benzyl-protected dialkyl acetal derivatives undergo desired aldol reaction with high diastereoselectivity using a Mukaiyama aldol reaction; intermediates in the synthesis of other products, including, e.g. Dolastatin 10 |
12/25/2007 | US7312245 controlling harmful drug resistant fungi at lower concentrations; safe for crops; rice blast |
12/20/2007 | US20070293700 Process for the Preparation of Gabapentin |
12/20/2007 | US20070293694 Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
12/20/2007 | US20070293573 Glu2 receptor modulators |
12/20/2007 | US20070293567 Substituted biphenyl carboxylic acids and derivatives thereof |
12/20/2007 | US20070293547 Compounds and Compositions as Lxr Modulators |
12/19/2007 | EP1866275A1 Crystalline forms of pregabalin |
12/19/2007 | EP1313560B1 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION |
12/19/2007 | EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
12/19/2007 | CN101090739A 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
12/19/2007 | CN100355723C Dimeglumine gadopentetate and its producing method |
12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
12/13/2007 | WO2007143152A2 Preparation of (s)-pregabalin-nitrile |
12/13/2007 | US20070287861 A Process Suitable for Industrial Scale Production of Gabapentin |
12/13/2007 | US20070287748 Intermediate in the synthesis of (S)-Pregabalin; precipitation |
12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
12/12/2007 | EP1863780A1 Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein |
12/12/2007 | EP1863755A1 Substituted aryl and heteroaryl derivatives |
12/12/2007 | EP0927174B1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds |
12/12/2007 | CN101087752A Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics |
12/12/2007 | CN101085875A Pigment dispersant and its preparation method and application |
12/12/2007 | CN101085745A Modified synthesis method for L-theanine |
12/12/2007 | CN100354256C Preparation of iminodiacetic acid compounds from monoethanolamine substrates |
12/12/2007 | CN100354251C Fused bicyclic or tricyclic amino acids |
12/11/2007 | US7307187 Oxidation of lauroyl monoalkanolamide with NaOBr, bromosuccinimide, bromoisocyanuric acid, oxone, or H2O2 and a hindered nitroxide; THF solvent creates two liquid phases separating the amidoalcohol from the oxidizing agent, amidoalcohol is partitioned into the liquid organic phase |
12/06/2007 | WO2007139724A1 2,5-di(methoxyanilino)terephthalic acid polymorphs and quinacridones realized therefrom |
12/06/2007 | WO2007139238A1 Process for l-carnitine and acetyl l-carnitine hydrochloride |
12/06/2007 | WO2007138324A2 Materials and complexes for the delivery of biologically-active material to cells |
12/06/2007 | WO2007137799A1 New synthesis of substituted hydroxymethyl phenols |
12/06/2007 | WO2007107008A8 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity |
12/06/2007 | US20070282127 strontium salt of an organic dicarboxylic acid, e.g. strontium malonate of high purity; reacting strontium hydroxide or strontium chloride with diacid in aqueous solution at given tempeature, pressure and molar ratio; end use as pharmaceutical, fertilizer, vitamins, in industrial products |
12/06/2007 | US20070281969 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
12/06/2007 | CA2650510A1 Materials and complexes for the delivery of biologically-active material to cells |
12/06/2007 | CA2649115A1 Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
12/06/2007 | CA2647398A1 New synthesis of substituted hydroxymethyl phenols |
12/05/2007 | EP1862446A2 Method for manufacturing enantiomer-enriched hydroxylamine derivatives |
12/05/2007 | EP1678198A4 Side chain deuterated amino acids and methods of use |
12/05/2007 | EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof |
12/05/2007 | EP1268397B1 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
12/05/2007 | EP1169294B1 Pharmaceutical compounds |
12/05/2007 | EP1052968B1 Alpha-amides of(l)-amino acids as fragrance precursors |
12/05/2007 | CN101081820A (Z)-4,4,4-trifluoro-3-hydroxyl-2-(dibenzyl amido)-2-butenoic acid ethyl and preparation method thereof |
12/05/2007 | CN100352803C Ethyl glycinate hydrochloride production method |
12/05/2007 | CN100352802C Contrast agent preparation |
12/05/2007 | CN100352801C Synthesis method of L-n-valaine |
12/04/2007 | US7304181 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides |
12/04/2007 | CA2418125C Beta-lactams useful in the preparation of substituted isoserine esters |
11/29/2007 | US20070276036 Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof |
11/29/2007 | US20070275858 Substituted spirocyclic ketoenols |
11/29/2007 | CA2652259A1 Substituted esters as cannabinoid-1 receptor modulators |
11/28/2007 | EP1860098A1 Novel anthranilic acid derivative or salt thereof |
11/28/2007 | EP1860094A1 Photocrosslinkable materials |
11/28/2007 | EP1858840A2 Analogs of 4-hydroxyisoleucine and uses thereof |
11/28/2007 | CN101077875A Boronic ester and acid compounds, synthesis and uses |
11/28/2007 | CN101077862A D-glucose-L-amino acid, preparation method and application thereof |
11/27/2007 | US7301031 Methods for producing hydroxy amino acids, esters, and derivatives thereof |
11/27/2007 | US7300775 Genetic engineered nucleic acid promoter |
11/22/2007 | WO2007132689A1 Process for production of radioactive fluorine-labeled organic compound |
11/22/2007 | WO2007132119A1 In situ or one-pot hydrogenation and reductive amination method |
11/22/2007 | WO2006108663A8 Method for recovering a basic amino acid from a fermentation liquor |
11/22/2007 | US20070270306 dehydrogenation of alcohols in the presence of doped hydrogenation catalysts, to form carboxylic acids and salts |
11/22/2007 | CA2651786A1 Process for production of radioactive fluorine-labeled organic compound |
11/21/2007 | EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
11/21/2007 | EP1585752B1 Polyene polyketides, processes for their production and their use as a pharmaceutical |
11/20/2007 | US7297820 Thio substituted stilbene amines; inhibiting the aggregation of amyloid proteins |
11/20/2007 | CA2139374C Polyaminated ligands and metal complexes thereof |